Alverson Luke 4
4 · CSW INDUSTRIALS, INC. · Filed Apr 7, 2026
Research Summary
AI-generated summary of this filing
CSW INDUSTRIALS SVP Luke Alverson Exercises Awards, Sells Shares
What Happened
Luke Alverson, SVP, General Counsel & Secretary of CSW Industrials (CSW), had performance-based awards vest and be settled in shares. The filing reports the acquisition of 3,347 shares from vested performance rights (no cash exercise price). To cover tax withholding, 1,333 of those shares were surrendered (valued at $260.34 each, $347,033). Separately, 1,007 shares were sold in the open market on a 10b5-1 plan for a weighted average proceeds of $266.11 per share ($267,973). The filing also shows a 1,731-share derivative conversion/disposition entry (reported as exercise/conversion).
Key Details
- Transaction dates: primary activity on 2026-04-02 (performance rights settlement and tax withholding); open-market sale reported on 2026-04-07. Filing date: 2026-04-07.
- Prices/values: tax-surrender 1,333 shares @ $260.34 = $347,033; open-market sale 1,007 shares @ weighted avg $266.11 = $267,973. Sale prices ranged $264.05–$268.8369 (weighted avg reported).
- Shares acquired via award: 3,347 performance-right-settled shares (vested at 190.7% of target per footnote).
- Shares disposed: 1,333 surrendered for tax withholding; 1,007 sold under a 10b5-1 trading plan; a 1,731-share derivative conversion/disposition is also reported.
- Footnotes: F1 (performance rights vested at 190.7% of target and were settled in shares, plus 24 dividend equivalents); F2 (open-market sale under a 10b5-1 plan established 12/01/2025); F3 (sale price is weighted avg; multiple trade prices in range).
- Shares owned after transaction: not specified in the information provided in this summary—see the Form 4 for ownership totals.
Context
These were performance awards that vested and were settled in shares (no cash exercise). The filing shows routine tax-withholding via share surrender and an open-market sale executed under a pre-established 10b5-1 plan—both common, non-speculative steps following award settlement. For full transaction detail (including the treatment of the 1,731-share derivative entry), consult the original Form 4 filing.
Insider Transaction Report
- Exercise/Conversion
Common Stock
[F1]2026-04-02+3,347→ 15,797 total - Tax Payment
Common Stock
2026-04-02$260.34/sh−1,333$347,033→ 14,464 total - Sale
Common Stock
[F2][F3]2026-04-07$266.11/sh−1,007$267,973→ 13,457 total - Exercise/Conversion
Performance Rights
[F1]2026-04-02−1,731→ 0 total→ Common Stock (1,731 underlying)
- 1,803(indirect: by ESOP)
Common Stock
Footnotes (3)
- [F1]Each performance right represented a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vested at a rate between 0% and 200% during a three-year performance cycle ending on March 31, 2026 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights, along with 24 dividend equivalent units, vested at 190.7% of the target award amount and were settled in shares of common stock pursuant to the award agreement terms.
- [F2]The transaction reported was effected pursuant to a 10b5-1 trading plan established by the reporting person on December 1, 2025.
- [F3]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $264.0500 to $268.8369, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.